Schlitt H J, Weimann A, Klempnauer J, Oldhafer K J, Nashan B, Raab R, Pichlmayr R
Klinik für Abdominal- und Transplantationschirurgie, Medizinische Hochschule Hannover, Germany.
Ann Surg. 1999 Feb;229(2):181-6. doi: 10.1097/00000658-199902000-00004.
To evaluate the concept of surgical decompression of the biliary tree by peripheral hepatojejunostomy for palliative treatment of jaundice in patients with irresectable malignant tumors of the liver hilum.
Jaundice, pruritus, and recurrent cholangitis are major clinical complications in patients with obstructive cholestasis resulting from malignant tumors of the liver hilum. Methods for palliative treatment include endoscopic stenting, percutaneous transhepatic drainage, and surgical decompression. The palliative treatment of choice should be safe, effective, and comfortable for the patient.
In a retrospective study, surgical technique, perioperative complications, and efficacy of treatment were analyzed for 56 patients who had received a peripheral hepatojejunostomy between 1982 and 1997. Laparotomy in all of these patients had been performed as an attempt for curative resection.
Hepatojejunostomy was exclusively palliative in 50 patients and was used for bridging to resection or transplantation in 7. Anastomosis was bilateral in 36 patients and unilateral in 20. The 1-month mortality in the study group was 9%; median survival was 6 months. In patients surviving >1 month, a marked and persistent decrease in cholestasis was achieved in 87%, although complete return to normal was rare. Among the patients with a marked decrease in cholestasis, 72% had no or only mild clinical symptoms such as fever or jaundice.
Peripheral hepatojejunostomy is a feasible and reasonably effective palliative treatment for patients with irresectable tumors of the liver hilum. In patients undergoing exploratory laparotomy for attempted curative resection, this procedure frequently leads to persistent-although rarely complete-decompression of the biliary tree. In a few cases it may also be used for bridging to transplantation or liver resection after relief of cholestasis.
评估通过外周肝空肠吻合术对肝门部不可切除恶性肿瘤患者进行胆道减压以姑息治疗黄疸的概念。
黄疸、瘙痒和复发性胆管炎是肝门部恶性肿瘤导致梗阻性胆汁淤积患者的主要临床并发症。姑息治疗方法包括内镜支架置入、经皮肝穿刺引流和手术减压。理想的姑息治疗应安全、有效且让患者舒适。
在一项回顾性研究中,分析了1982年至1997年间接受外周肝空肠吻合术的56例患者的手术技术、围手术期并发症及治疗效果。所有这些患者均接受了剖腹手术,试图进行根治性切除。
50例患者的肝空肠吻合术仅用于姑息治疗,7例用于过渡到切除或移植。36例患者为双侧吻合,20例为单侧吻合。研究组1个月死亡率为9%;中位生存期为6个月。存活超过1个月的患者中,87%的胆汁淤积明显且持续减轻,尽管很少完全恢复正常。在胆汁淤积明显减轻的患者中,72%没有或仅有轻度临床症状,如发热或黄疸。
外周肝空肠吻合术对于肝门部不可切除肿瘤患者是一种可行且相当有效的姑息治疗方法。在接受剖腹探查试图进行根治性切除的患者中,该手术常常能使胆道得到持续(尽管很少完全)减压。在少数情况下,它也可用于在胆汁淤积缓解后过渡到移植或肝切除。